{
    "accession": "ENCBS854ZPI",
    "age": "15",
    "age_units": "year",
    "applied_modifications": [
        {
            "category": "insertion",
            "introduced_tags": [
                {
                    "location": "C-terminal",
                    "name": "eGFP"
                }
            ],
            "method": "CRISPR",
            "modified_site_by_target_id": "NR2F1",
            "purpose": "tagging",
            "reagents": [
                {
                    "identifier": "addgene:112388",
                    "source": "/sources/addgene/",
                    "url": "https://www.addgene.org/112388/"
                },
                {
                    "identifier": "addgene:112484",
                    "source": "/sources/addgene/",
                    "url": "https://www.addgene.org/112484/"
                }
            ]
        }
    ],
    "biosample_term_id": "EFO:0001187",
    "biosample_term_name": "HepG2",
    "biosample_type": "cell line",
    "characterizations": [],
    "dbxrefs": [],
    "description": "HepG2 cell line stably expressing a C-terminal LAP-tag containing eGFP, fused to NR2F1.",
    "documents": [],
    "donor": "ENCDO000AAC",
    "health_status": "hepatocellular carcinoma",
    "lab": "Michael Snyder, Stanford",
    "life_stage": "child",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "male",
    "source": "Michael Snyder",
    "summary": "Homo sapiens HepG2 cell line genetically modified (insertion) using CRISPR targeting H. sapiens NR2F1",
    "treatments": []
}